Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Other Non Operating Income (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Other Non Operating Income for 6 consecutive years, with $17337.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non Operating Income rose 18.08% to $17337.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $83917.0, a 511.88% increase, with the full-year FY2024 number at $17277.0, up 12.04% from a year prior.
  • Other Non Operating Income was $17337.0 for Q3 2025 at Ensysce Biosciences, down from $21011.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $611556.0 in Q4 2021 to a low of -$307981.0 in Q2 2021.
  • A 5-year average of $44550.6 and a median of $8678.0 in 2022 define the central range for Other Non Operating Income.
  • Biggest YoY gain for Other Non Operating Income was 472.9% in 2024; the steepest drop was 736.45% in 2024.
  • Ensysce Biosciences' Other Non Operating Income stood at $611556.0 in 2021, then crashed by 89.09% to $66729.0 in 2022, then plummeted by 111.93% to -$7962.0 in 2023, then skyrocketed by 472.9% to $29690.0 in 2024, then tumbled by 41.61% to $17337.0 in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Other Non Operating Income are $17337.0 (Q3 2025), $21011.0 (Q2 2025), and $15879.0 (Q1 2025).